Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
49,86 USD | +4,03 % | +4,90 % | -16,71 % |
Resumen de negocios
Número de empleados: 704
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutic Compounds
100,0
%
| 75 | 100,0 % | 397 | 100,0 % | +425,83 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 75 | 100,0 % | 397 | 100,0 % | +425,83 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 54 | 25/09/09 | |
Cedric Francois
FOU | Founder | 51 | 25/09/09 |
Timothy Sullivan
DFI | Director of Finance/CFO | 53 | 01/10/17 |
Caroline Baumal
CTO | Chief Tech/Sci/R&D Officer | 57 | 03/01/23 |
Adam Townsend
COO | Chief Operating Officer | 47 | 20/11/18 |
Lukas Scheibler
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/04/19 |
Meredith Kaya
IRC | Investor Relations Contact | - | - |
Jeffrey Eisele
PRN | Corporate Officer/Principal | - | 01/01/20 |
Vahe Ghahraman
LAW | General Counsel | - | 01/04/19 |
Thomas Lackner
PRN | Corporate Officer/Principal | - | 31/01/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alec Machiels
FOU | Founder | 51 | 25/09/09 |
Director/Board Member | 65 | 01/07/13 | |
Andrew Dunlop
BRD | Director/Board Member | 52 | 01/03/10 |
Cedric Francois
FOU | Founder | 51 | 25/09/09 |
Founder | 54 | 25/09/09 | |
Lok Chung Chan
CHM | Chairman | 73 | 01/07/13 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 120 581 749 | 104 637 200 ( 86,78 %) | 0 | 86,78 % |
Información de la empresa
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-16,71 % | 6012,21 M | |
-4,66 % | 86,13 mil M | |
+1,32 % | 39,82 mil M | |
-19,27 % | 30,42 mil M | |
+57,86 % | 25,23 mil M | |
-17,69 % | 11,6 mil M | |
-43,00 % | 11,51 mil M | |
-9,14 % | 11,95 mil M | |
+5,24 % | 8710,47 M | |
-8,42 % | 8115,21 M |
- Bolsa de valores
- Acciones
- Acción APLS
- Empresa Apellis Pharmaceuticals, Inc.